See you tomorrow at #ASGCT23! We’re excited to share new data from our lead program targeting 𝘈𝘉𝘊𝘈4 retinopathies.

At 9am PT, #TeamAscidian’s Head of Research will present on how we’re #RewritingRNA for the treatment of #Stargardt disease.
👉 https://bit.ly/3MBG592

Join our Head of Research, Robert Bell, at the Annual Locust Walk RNA Innovation Conference on May 9th as he presents information on how Ascidian is redefining the treatment of disease by #RewritingRNA.

Register here 👉 https://bit.ly/3LFgoTo

Good news! 📣 If you missed the WuXi AppTec Global Forum timed to the JPM Healthcare conference in January, the digital broadcast will be available tomorrow. Here's a preview of the RNA therapeutics panel featuring our CEO Romesh Subramanian sharing Ascidian's unique approach to #RewritingRNA by editing exons in a single reaction, with a single construct.

Catch the full event tomorrow to see global experts #TakingBOLDAction to advance breakthroughs for patients. 🎟️ 👇
https://www.linkedin.com/feed/update/urn:li:ugcPost:7046851451356139520/

🗣️📢 It’s Ascidian’s podcast debut! Listen to our CEO Romesh Subramanian discuss our unique #ExonEditing approach (#RewritingRNA), the inspiration behind our name, and his pick on where to grab lunch in Boston.

Check out the Cell & Gene podcast with Erin Harris here!👇
http://bit.ly/400PMSq